Empowering STAT DNA Testing Using a Fully Automated Platform

Unless otherwise noted, P.A.C.E.™ accreditation will expire six months after the live webinar.

Turnaround time remains a major issue in molecular biomarker testing. Current technologies are complex, difficult to implement and require a lot of hands-on time, all of which adds to the time it takes to get a result.

This complimentary, P.A.C.E.-accredited Fisher Healthcare™ webinar will provide a firsthand perspective about how new technologies can help improve turnaround time for virtually any lab. Dr. Gregory Tsongalis will discuss his experiences with fully automated molecular biomarker analyses, present results from a recent performance study, and share his views on validation requirements for such testing. 

Learning Objectives

This webinar will help you:

• Summarize the increased demand for shorter testing times when measuring oncology biomarkers
• Compare the performance of a fully automated qPCR-based system to that of a system based on next-generation sequencing
• Identify validation strategies for implementing fully automated biomarker testing systems in CLIA-regulated settings

Watch On Demand      View Slides

This webinar is produced by Whitehat Communications, a provider of continuing education programs in clinical laboratory sciences that has been approved by the ASCLS P.A.C.E. Program. One P.A.C.E. credit hour will be provided for this complimentary, basic-level program.

Gregory J. Tsongalis, PhD, HCLD, CC

Dr. Tsongalis is a Professor of Pathology and Laboratory Medicine and the current Director of Laboratory for Clinical Genomics and Advanced Technology (CGAT) in the Pathology and Laboratory Medicine Department at the Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH.

He received a Bachelor of Science in zoology from the University of Massachusetts, Amherst, and a Master of Health Science as a Pathology Assistant from Quinnipiac College in Hamden, CT. In 1990, he received his PhD in Pathology from the University of Medicine and Dentistry of New Jersey and completed his postdoctoral training in Pathology and Laboratory Medicine at the University of North Carolina at Chapel Hill. From 1994 to 2004, Dr. Tsongalis was the Director of Molecular Pathology at Hartford Hospital (CT) and an adjunct faculty member in the School of Allied Health at the University of Connecticut, Storrs. In 2004, he joined the faculty of the Geisel School of Medicine at Dartmouth and became the director of the molecular pathology service at the Dartmouth Hitchcock Medical Center in Lebanon, NH.

With research interests in the pathogenesis of solid tumors, disease association of SNP genotyping, and personalized medicine, he has authored and edited 11 textbooks in the field of molecular pathology, published more than 200 peer-reviewed manuscripts, and been an invited speaker at both national and international meetings. Dr. Tsongalis has been the recipient of numerous investigator/scientist awards and has served on numerous committees of the NHGRI, AACC, ASIP, and AMP where he is a past President. He serves on the editorial board of nine journals including Clinical Chemistry and the Journal of Molecular Diagnostics, as well as numerous corporate scientific advisory boards.